Dr. Husam H. Alkhersam, MD

Dr. Alkhersam practices at Icare Health Surgical Suites LLC in Bedford, Texas.

Dr. Alkhersam's NPI, 1336124429, was assigned on December 12, 2005. Dr. Alkhersam graduated from University of Al-Mustansiriyah College of Medicine in 1989. Dr. Alkhersam holds Texas license L4214.

Dr. Alkhersam's primary practice is Icare Health Surgical Suites LLC, at 1604 Hospital Pkwy, Bedford, TX 76022 in Tarrant County. The practice phone is (682) 688-2020.

Dr. Alkhersam's primary practice is Icare Health Surgical Suites LLC in Bedford, Texas. Dr. Alkhersam is also affiliated with Texas Health Harris Methodist Hospital Hurst-Euless-Bedford. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Alkhersam to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alkhersam practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Alkhersam's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Alkhersam is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Alkhersam's licenses on file in 4 states: Texas, Maine, Oklahoma and Michigan.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain and hereditary polyneuropathy among the conditions Dr. Alkhersam treats.

CMS data shows 7,045 Medicare services from Dr. Alkhersam across 13 procedure codes in 2024, for 451 Medicare patients. Medicare paid $100,400 for them. Every service was in an office.

CMS counts 451 Medicare patients who saw Dr. Alkhersam in 2024. The largest group is 65 to 74, with 200 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alkhersam's median patient age at 67, with 58% women.

In 2024, Dr. Alkhersam wrote 3,025 Medicare Part D claims for 596 patients. 87% of them were for generic drugs. CMS names the drug for 2,756 of them, across 62 drugs with 11 or more claims each, at $889,494 in total drug cost. In 2023, CMS named 2,591 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 73 out of 100 for Dr. Alkhersam for performance year 2024, reported individually. Dr. Alkhersam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Alkhersam. Dr. Alkhersam's most frequent co-authors are Jonathan S. Katz, MD and Sharon P. Nations, MD.

CMS Open Payments shows 737 general payments to Dr. Alkhersam from 67 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Allergan Inc. paid the most, $5,469.

Dmand AI lists 2 awards for Dr. Alkhersam, most recently CMS Stage 1 EHR in 2013.

Dr. Alkhersam graduated from University of Al-Mustansiriyah College of Medicine in 1989.

Dr. Alkhersam is in network with 22 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.